Resultados da busca - Longet, Stephanie
- Mostrando 1 - 20 resultados de 28
- Ir para a próxima página
-
1
-
2
-
3
-
4
Secretory IgA in complex with Lactobacillus rhamnosus potentiates mucosal dendritic cell-mediated Treg cell differentiation via TLR regulatory proteins, RALDH2 and secretion of IL-... por Mikulic, Josip, Longet, Stéphanie, Favre, Laurent, Benyacoub, Jalil, Corthesy, Blaise
Publicado em 2017Texto -
5
A Murine Genital-Challenge Model Is a Sensitive Measure of Protective Antibodies against Human Papillomavirus Infection por Longet, Stéphanie, Schiller, John T., Bobst, Martine, Jichlinski, Patrice, Nardelli-Haefliger, Denise
Publicado em 2011Texto -
6
Reconstituted Human Polyclonal Plasma-derived Secretory-like IgM and IgA Maintain the Barrier Function of Epithelial Cells Infected with an Enteropathogen por Longet, Stéphanie, Vonarburg, Cédric, Lötscher, Marius, Miescher, Sylvia, Zuercher, Adrian, Corthésy, Blaise
Publicado em 2014Texto -
7
-
8
Human Plasma-derived Polymeric IgA and IgM Antibodies Associate with Secretory Component to Yield Biologically Active Secretory-like Antibodies por Longet, Stéphanie, Miled, Sarah, Lötscher, Marius, Miescher, Sylvia M., Zuercher, Adrian W., Corthésy, Blaise
Publicado em 2013Texto -
9
Type II NKT Cell Agonist, Sulfatide, Is an Effective Adjuvant for Oral Heat-Killed Cholera Vaccines por Albutti, Aqel, Longet, Stephanie, McEntee, Craig P., Quinn, Shauna, Liddicoat, Alex, Rîmniceanu, Cristiana, Lycke, Nils, Lynch, Lydia, Cardell, Susanna, Lavelle, Ed C.
Publicado em 2021Texto -
10
An oral alpha-galactosylceramide adjuvanted Helicobacter pylori vaccine induces protective IL-1R- and IL-17R-dependent Th1 responses por Longet, Stephanie, Abautret-Daly, Aine, Davitt, Christopher J. H., McEntee, Craig P., Aversa, Vincenzo, Rosa, Monica, Coulter, Ivan S., Holmgren, Jan, Raghavan, Sukanya, Lavelle, Ed C.
Publicado em 2019Texto -
11
Technological Approaches for Improving Vaccination Compliance and Coverage por Lemoine, Céline, Thakur, Aneesh, Krajišnik, Danina, Guyon, Romain, Longet, Stephanie, Razim, Agnieszka, Górska, Sabina, Pantelić, Ivana, Ilić, Tanja, Nikolić, Ines, Lavelle, Ed C., Gamian, Andrzej, Savić, Snežana, Milicic, Anita
Publicado em 2020Texto -
12
Alpha-galactosylceramide enhances mucosal immunity to oral whole-cell cholera vaccines por Davitt, Christopher J. H., Longet, Stephanie, Albutti, Aqel, Aversa, Vincenzo, Nordqvist, Stefan, Hackett, Becky, McEntee, Craig P., Rosa, Monica, Coulter, Ivan S., Lebens, Michael, Tobias, Joshua, Holmgren, Jan, Lavelle, Ed C.
Publicado em 2019Texto -
13
Pseudotyping of VSV with Ebola virus glycoprotein is superior to HIV-1 for the assessment of neutralising antibodies por Steeds, Kimberley, Hall, Yper, Slack, Gillian S., Longet, Stephanie, Strecker, Thomas, Fehling, Sarah Katharina, Wright, Edward, Bore, Joseph Akoi, Koundouno, Fara Raymond, Konde, Mandy Kader, Hewson, Roger, Hiscox, Julian A., Pollakis, Georgios, Carroll, Miles W.
Publicado em 2020Texto -
14
Complement-Mediated Neutralisation Identified in Ebola Virus Disease Survivor Plasma: Implications for Protection and Pathogenesis por Mellors, Jack, Tipton, Tom, Fehling, Sarah Katharina, Akoi Bore, Joseph, Koundouno, Fara Raymond, Hall, Yper, Hudson, Jacob, Alexander, Frances, Longet, Stephanie, Taylor, Stephen, Gorringe, Andrew, Magassouba, N’Faly, Konde, Mandy Kader, Hiscox, Julian, Strecker, Thomas, Carroll, Miles
Publicado em 2022Texto -
15
SARS-CoV-2-Specific T Cell Responses Are Not Associated with Protection against Reinfection in Hemodialysis Patients por Shankar, Sushma, Beckett, Joseph, Tipton, Tom, Ogbe, Ane, Kasanyinga, Mwila, Dold, Christina, Lumley, Sheila, Dengu, Fungai, Rompianesi, Gianluca, Elgilani, Faysal, Longet, Stephanie, Deeks, Alexandra, Payne, Rebecca P., Duncan, Christopher J.A., Richter, Alex, de Silva, Thushan I., Turtle, Lance, Bull, Katherine, Barnardo, Martin, Friend, Peter J., Dunachie, Susanna J., Hester, Joanna, Issa, Fadi, Barnes, Eleanor, Carroll, Miles W., Klenerman, Paul
Publicado em 2022Texto -
16
One or two dose regimen of the SARS-CoV-2 synthetic DNA vaccine INO-4800 protects against respiratory tract disease burden in nonhuman primate challenge model por Gooch, Karen E., Smith, Trevor R.F., Salguero, Francisco J., Fotheringham, Susan A., Watson, Robert J., Dennis, Mike J., Handley, Alastair, Humphries, Holly E., Longet, Stephanie, Tipton, Tom, Sarfas, Charlotte, Sibley, Laura, Slack, Gillian S., Rayner, Emma, Ryan, Kathryn A., Schultheis, Katherine, Ramos, Stephanie J., White, Andrew, Charlton, Sue, Sharpe, Sally A., Gleeson, Fergus, Humeau, Laurent M., Hall, Yper, Broderick, Kate E., Carroll, Miles W.
Publicado em 2021Texto -
17
Influence of Aerosol Delivered BCG Vaccination on Immunological and Disease Parameters Following SARS-CoV-2 Challenge in Rhesus Macaques por White, Andrew D., Sibley, Laura, Sarfas, Charlotte, Morrison, Alexandra L., Bewley, Kevin, Churchward, Colin, Fotheringham, Susan, Gkolfinos, Konstantinos, Gooch, Karen, Handley, Alastair, Humphries, Holly E., Hunter, Laura, Kennard, Chelsea, Longet, Stephanie, Mabbutt, Adam, Moffatt, Miriam, Rayner, Emma, Tipton, Tom, Watson, Robert, Hall, Yper, Bodman-Smith, Mark, Gleeson, Fergus, Dennis, Mike, Salguero, Francisco J., Carroll, Miles, McShane, Helen, Cookson, William, Hopkin, Julian, Sharpe, Sally
Publicado em 2022Texto -
18
T cell and humoral immune response to multiple SARS-CoV-2 variants including omicron (B1.1.529) after two doses of COVID-19 vaccine in patients with cirrhosis and liver diseases re... por Murray, Sam, Longet, Stephanie, Tipton, Tom, Londoño, Maria Carlota, Pose, Elisa, Laidlaw, Stephen, Nguyen, Dung, Meacham, Georgina, Lim, Zixiang, Dimitriadis, Stavros, Irwin, Sophie, Cook, Jonathan, Iavarone, Massimo, Lampertico, Pietro, Hernandez-Gea, Virginia, Garcia Pagan, Juan Carlos, zur Wiesch, Julian Schulze, Sterneck, Martina, Russo, Francesco Paolo, Satsangi, Jack, Dunachie, Susanna, Klenerman, Paul, Goodyear, Carl, McInnes, Iain B., Ginès, Pere, Carroll, Miles, Marjot, Thomas, Barnes, Eleanor
Publicado em 2022Texto -
19
Safety, tolerability, viral kinetics, and immune correlates of protection in healthy, seropositive UK adults inoculated with SARS-CoV-2: a single-centre, open-label, phase 1 contro... por Jackson, Susan, Marshall, Julia L, Mawer, Andrew, Lopez-Ramon, Raquel, Harris, Stephanie A, Satti, Iman, Hughes, Eileen, Preston-Jones, Hannah, Puig, Ingrid Cabrera, Longet, Stephanie, Tipton, Tom, Laidlaw, Stephen, Doherty, Rebecca Powell, Morrison, Hazel, Mitchell, Robert, Tanner, Rachel, Ateere, Alberta, Stylianou, Elena, Wu, Meng-San, Fredsgaard-Jones, Timothy P W, Breuer, Judith, Rapeport, Garth, Ferreira, Vanessa M, Gleeson, Fergus, Pollard, Andrew J, Carroll, Miles, Catchpole, Andrew, Chiu, Christopher, McShane, Helen
Publicado em 2024Texto -
20
Two doses of SARS-CoV-2 vaccination induce robust immune responses to emerging SARS-CoV-2 variants of concern por Skelly, Donal T., Harding, Adam C., Gilbert-Jaramillo, Javier, Knight, Michael L., Longet, Stephanie, Brown, Anthony, Adele, Sandra, Adland, Emily, Brown, Helen, Tipton, Tom, Stafford, Lizzie, Mentzer, Alexander J., Johnson, Síle A., Amini, Ali, Tan, Tiong Kit, Schimanski, Lisa, Huang, Kuan-Ying A., Rijal, Pramila, Frater, John, Goulder, Philip, Conlon, Christopher P., Jeffery, Katie, Dold, Christina, Pollard, Andrew J., Sigal, Alex, de Oliveira, Tulio, Townsend, Alain R., Klenerman, Paul, Dunachie, Susanna J., Barnes, Eleanor, Carroll, Miles W., James, William S.
Publicado em 2021Texto